Centene (CNC) Expected to Announce Quarterly Earnings on Tuesday

Centene (NYSE:CNC) is expected to be announcing its Q1 2026 results before the market opens on Tuesday, April 28th. Analysts expect the company to announce earnings of $2.12 per share and revenue of $47.5832 billion for the quarter. Centene has set its FY 2026 guidance at 3.000-3.000 EPS. Investors are encouraged to explore the company’s upcoming Q1 2026 earning overview page for the latest details on the call scheduled for Tuesday, April 28, 2026 at 8:30 AM ET.

Centene (NYSE:CNC) last issued its quarterly earnings results on Friday, February 6th. The company reported ($1.19) earnings per share (EPS) for the quarter, topping the consensus estimate of ($1.22) by $0.03. The business had revenue of $49.73 billion for the quarter, compared to the consensus estimate of $48.41 billion. Centene had a negative net margin of 3.43% and a positive return on equity of 4.25%. The firm’s quarterly revenue was up 21.9% on a year-over-year basis. During the same quarter in the prior year, the company earned $0.80 EPS. On average, analysts expect Centene to post $3 EPS for the current fiscal year and $4 EPS for the next fiscal year.

Centene Stock Up 1.8%

Shares of NYSE CNC opened at $41.85 on Friday. The company has a quick ratio of 1.10, a current ratio of 1.10 and a debt-to-equity ratio of 0.87. Centene has a 12-month low of $25.08 and a 12-month high of $64.15. The company has a market cap of $20.58 billion, a price-to-earnings ratio of -3.07, a price-to-earnings-growth ratio of 0.91 and a beta of 0.59. The firm’s 50-day simple moving average is $38.26 and its 200 day simple moving average is $39.10.

Hedge Funds Weigh In On Centene

A number of large investors have recently bought and sold shares of CNC. Baird Financial Group Inc. acquired a new position in Centene during the 1st quarter worth approximately $236,000. Sivia Capital Partners LLC boosted its position in Centene by 80.0% during the 2nd quarter. Sivia Capital Partners LLC now owns 9,710 shares of the company’s stock worth $527,000 after acquiring an additional 4,315 shares during the last quarter. CW Advisors LLC boosted its position in Centene by 20.3% during the 2nd quarter. CW Advisors LLC now owns 4,863 shares of the company’s stock worth $264,000 after acquiring an additional 820 shares during the last quarter. NewEdge Advisors LLC boosted its position in Centene by 6.1% during the 2nd quarter. NewEdge Advisors LLC now owns 44,945 shares of the company’s stock worth $2,440,000 after acquiring an additional 2,582 shares during the last quarter. Finally, Treasurer of the State of North Carolina boosted its position in Centene by 0.4% during the 2nd quarter. Treasurer of the State of North Carolina now owns 231,938 shares of the company’s stock worth $12,590,000 after acquiring an additional 967 shares during the last quarter. Institutional investors and hedge funds own 93.63% of the company’s stock.

Analyst Ratings Changes

CNC has been the topic of a number of research reports. JPMorgan Chase & Co. cut their target price on shares of Centene from $45.00 to $41.00 and set a “neutral” rating on the stock in a research report on Thursday, March 19th. Cantor Fitzgerald reaffirmed a “neutral” rating and issued a $41.00 price target on shares of Centene in a research note on Monday, February 9th. Weiss Ratings reaffirmed a “sell (d)” rating on shares of Centene in a research note on Monday, April 20th. Morgan Stanley upped their price target on Centene from $38.00 to $45.00 and gave the company an “equal weight” rating in a research note on Wednesday, March 4th. Finally, Mizuho set a $41.00 target price on Centene and gave the stock a “neutral” rating in a research note on Tuesday, March 10th. Three research analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and three have issued a Sell rating to the company’s stock. According to MarketBeat.com, Centene presently has a consensus rating of “Hold” and an average price target of $42.00.

About Centene

Centene Corporation (NYSE: CNC) is a diversified, multi-national healthcare enterprise that specializes in providing services to government-sponsored and national health programs. The company primarily acts as a managed care organization, delivering healthcare coverage and administering benefits for Medicaid, the Children’s Health Insurance Program (CHIP), Medicare Advantage, and individual marketplace plans. Centene also contracts with federal and state agencies to manage specialty care programs and community-based services for vulnerable populations.

Centene’s offerings extend beyond traditional insurance to include a range of specialty and support services.